# Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants

> **NCT03939702** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 9 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** BMS-986177

## Key facts

- **NCT ID:** NCT03939702
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-02
- **Primary completion:** 2019-07-11
- **Final completion:** 2019-07-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03939702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03939702, "Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03939702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*